Market Research Logo

Prescription Drugs Market Research Reports & Industry Analysis

In April 2011, the Food and Drug Administration (FDA) announced a new program focused on curbing the abuse and reducing associated risks of prescription opioid painkillers. The Risk Evaluation and Mitigation Strategy (REMS) program focuses primarily on educating doctors about proper pain management, patient selection and improving patient awareness about how to use these drugs safely.

According to the White House, prescription drug abuse has become an epidemic, estimating that in 2007 alone, over 33 million Americans age 12 and older misused opioid painkillers. That same year, drug overdose in the U.S. was one of the leading causes of unintentional injury death, second only to motor vehicle accidents.

One important target of the campaign is the safe disposal of medications. In many cases, doctors have been found to prescribe larger doses of opioids than patients actually use. Many of these pills find their way onto the black market. Additionally, more than half of all non-prescribed painkiller users get their drugs from someone they know. As part of the plan, FDA wants opioid manufacturers to provide prescribing physicians with educational materials, including a medication guide that uses consumer friendly language to explain safe use and disposal.

The drugs targeted by the REMS plan include brand name products known under the generic names hydromorphone, oxycodone, morphine, oxymorphone, methadone, transdermal fentanyl, and transdermal buprenorphine.

...Show More ...Show Less


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Prescription Drugs Industry Research & Market Reports

  • Global Antithrombotic Drugs Market Forecast 2018-2026

    ... Antithrombotic drugs market is anticipated to evolve further at a CAGR of 6.83% over the forecast period of 2018-2026. MARKET INSIGHTS The antithrombotic drug market is segmented on the basis of anticoagulants, antiplatelet and thrombin ... Read More

  • Addiction Prevention and Monitoring: Leveraging DX to Tackle the Opioid Epidemic in Kentucky

    ... blood-borne diseases, and neonatal abstinence syndrome. Opioid addiction impacts lives, families, communities, hospitals, schools, EMS, and police. Kentucky public health officials are tackling this epidemic and deploying digital transformation (DX) initiatives to target chronic conditions ... Read More

  • Global Pharmaceuticals Industry Profile & Value Chain Analysis

    ... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. The value/supply chain analysis reveals the business activities which comprise the global pharmaceuticals market’s value/supply chain. All ... Read More

  • Depression Treatment Drugs Markets in China

    ... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More

  • Blood Disease Drugs Markets in China

    ... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More

  • Mental Illness Drugs Markets in China

    ... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More

  • Osteoporosis Drugs Markets in China

    ... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More

  • Depression Treatment Drugs Industry Forecasts - China Focus

    ... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More

  • Pediatric Drugs Markets in China

    ... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More

  • Depression Treatment Drugs Companies in China

    ... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More

  • Hypertension Drugs Markets in China

    ... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More

  • Rx/Reimbursement Adult Incontinence in France

    ... is projected to grow by 11% over the forecast period; and older consumers tend to be more in need of moderate/heavy incontinence products. These products typically carry higher unit prices and are, therefore, more likely ... Read More

  • Global Warts Market Research Report 2018

    ... the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Warts basics: definitions, classifications, applications and market overview; ... Read More

  • Rx/Reimbursement Adult Incontinence in Belgium

    ... incurable disease, fills in a form to attest to the incontinence. The patient then has to take this form to the health fund he/she is affiliated to and will receive an allocation of EUR162.3 per ... Read More

  • Global and Chinese Expectorant Industry, 2018 Market Research Report

    ... report provides key statistics on the market status of the Expectorant manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview ... Read More

  • Global Compounding Pharmacy Market Research Report 2018

    ... analyzes the top players in global and major regions, and splits the Compounding Pharmacy market by product type and applications/end industries. Compounded medications are made based on a practitioner¡¯s prescription in which individual ingredients are ... Read More

  • Italy Pharmaceuticals & Healthcare Q2 2018

    ... pre-global financial crisis peaks. Weak growth and Italy's massive debt will act as a long-termconstraint on government spending, despite expansionary fiscal policy proposals featuring prominently in the platforms of eachparty. Therefore, it is our view ... Read More

  • Gabon Pharmaceuticals & Healthcare Q2 2018

    ... signal greater commercial potential fordrugmakers, however, exploiting these opportunities will be challenging in nature as the undeveloped status of the country'spharmaceutical and healthcare markets poses a much less receptive environment for drugmaker opportunities in Sub-SaharanAfrica. Read More

  • Kyrgyzstan Pharmaceuticals & Healthcare Q2 2018

    ... growth, the lack of regulatory oversight will create a challenging environment,creating a major access barrier to drugmakers. Moreover, affordability levels are low, resulting in drug demand almost exclusivelywithin the non-branded generic and over-the-counter medicines sectors. Read More

  • Hong Kong Pharmaceuticals & Healthcare Q2 2018

    ... aggregate market size. While the HospitalAuthority (HA) continues to receive the lion's share of resources, other areas such as healthcare manpower training and promotionof healthy lifestyles in order to reduce the non-communicable disease burden and ... Read More

  • Myanmar Pharmaceuticals & Healthcare Q2 2018

    ... limit the uptakeof medicines and challenge pharmaceutical companies' revenue-earning potential. Despite this, the private healthcare providers inMyanmar will be well positioned for growth. Supporting this trajectory is the underdeveloped state of the public health sector ... Read More

  • Mozambique Pharmaceuticals & Healthcare Q2 2018

    ... significantly low as a result of widespread poverty amongst the population, limiting potential revenue prospects for drugmakers.Furthermore, weak intellectual property standards and a poorly enforced pricing regime make Mozambique a high-risk environmentfor innovative medicine producers. Read More

  • Turkey Pharmaceuticals & Healthcare Report Q2 2018

    ... will support market growth, driven by the Health TransformationPlan. However, we highlight that macro risks will increasingly place downside risks to this expansionary fiscal outlook, leading togrowth deceleration over the long term. Moreover, innovative drugmakers ... Read More

  • Costa Rica Pharmaceuticals & Healthcare Q2 2018

    ... America region. It offers superior market access and development opportunities tomultinationals, based on factors such as continuous improvement in healthcare infrastructure and government commitment toupholding an attractive business environment. Additionally, the demand for innovative medicines ... Read More

  • Ghana Pharmaceuticals & Healthcare Q2 2018

    ... over innovative multinational firms. In order to ensure thepopulation’s healthcare and access to safe medicines are not compromised by such measures, protectionist policies aimed atboosting local drugmaker capabilities must be accompanied by improvements to medical ... Read More

< prev 1 3 4 5 6 7 8 9 10